| Cryo-EM structure of thiamine-bound human SLC19A3 in inward-open state | |
Heteromer
| 11-459 | 99.47 | 1×VIB; |
|
| Cryo-EM structure of apo human SLC19A3 in inward-open state | |
Heteromer
| 11-459 | 100.0 | 1×NAG; |
|
| Cryo-EM structure of hydroxychloroquine-bound human SLC19A3 in inward-open state | |
Heteromer
| 11-459 | 100.0 | 1×NAG; 1×A1H5D; |
|
| Cryo-EM structure of fedratinib-bound human SLC19A3 in inward-open state | |
Heteromer
| 11-459 | 99.47 | 1×2TA; |
|
| Cryo-EM structure of apo human SLC19A3 in outward-open state | |
Heteromer
| 11-459 | 100.0 | 1×NAG; |
|
| Cryo-EM structure of thiamine-bound human SLC19A3 in outward-open state | |
Heteromer
| 11-459 | 100.0 | 1×NAG; 1×VIB; |
|
| Cryo-EM structure of amprolium-bound human SLC19A3 in inward-open state | |
Heteromer
| 11-459 | 99.47 | 1×A1H5C; |
|
| SLC19A3-Fedratinib inward structure | | monomer | 13-466 | 100.0 | 1×2TA; |
|
| SLC19A3 apo structure | | monomer | 11-461 | 100.0 | |
|
| SLC19A3-thiamine outward structure | | monomer | 11-461 | 100.0 | 1×VIB; |
|
| SLC19A3-Pyridoxine outward structure | | monomer | 11-461 | 100.0 | 1×UEG; |
|
| SLC19A3-Fedratinib outward structure | | monomer | 11-461 | 100.0 | 1×2TA; |
|
| Slc19A3-Amprolium outward structure | | monomer | 11-461 | 100.0 | 1×A1H5C; |
|
| SLC19A3-Metformin outward structure | | monomer | 11-461 | 100.0 | 1×MF8; |
|
| SLC19A3-Thiamine inward structure | | monomer | 13-461 | 100.0 | 1×VIB; |
|
| Thiamine-bound human SLC19A3 | | monomer | 11-459 | 100.0 | 1×VIB; |
|
| Pyridoxamine-bound human SLC19A3 | | monomer | 11-459 | 100.0 | 1×PXM; |
|
| Fedratinib-bound human SLC19A3 | | monomer | 11-459 | 100.0 | 1×2TA; |
|